Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

UNKNOWN 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 12Other hematologic neoplasm 11Breast 10Plasma cell 8Gastrointestinal 8Gynecologic 7Myeloid 6Thoracic 4Dermatologic 4CNS 4Head & Neck 3Genitourinary 3Tumor-Agnostic 1

Conditions

Vomiting 2Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Nausea 1Head and Neck Neoplasms 1

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Aprepitant × Head & Neck × Clear all
NCT06697782 2025-01-22

Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 4 Completed
600 enrolled
Head & Neck

Thyroid Neoplasms

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

ChineseAMS

Phase 2 Unknown
43 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT03572829 2020-07-15

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

ChineseAMS

Phase 2 Completed
44 enrolled
Head & Neck

Head and Neck Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡